Myriad Pharmaceuticals Acquires Javelin Pharmaceuticals for Undisclosed Sum

  • Feed Type
  • Date
    12/21/2009
  • Company Name
    Javelin Pharmaceuticals
  • Mailing Address
    125 CambridgePark Drive Cambridge, MA 02140
  • Company Description
    Javelin is a specialty pharmaceutical company that applies innovative proprietary delivery technologies to develop new, improved formulations of existing drugs that target unmet and underserved medical needs in the growing pain management market.
  • Website
    http://www.javelinpharmaceuticals.com
  • Transaction Type
    M&A
  • Transaction Amount
    Undisclosed
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    The merger, which is expected to close in the first quarter of 2010, has been approved by the boards of both companies but must also be approved by the shareholders of each firm.

Trending on Xconomy